Document is current
Any future updates will be listed below
-
Authors
Zhu, Dagny https://orcid.org/0000-0001-7784-5202
Karki, Suyen https://orcid.org/0000-0002-2293-191X
Dhariwal, Mukesh https://orcid.org/0000-0001-8429-8462
Soini, Erkki https://orcid.org/0000-0003-4259-7610
Asseburg, Christian https://orcid.org/0000-0001-7196-3363
-
Funding
Funding for this research was provided by:
Alcon Vision LLC, Fort Worth, Texas, USA
- License Information
-
More Information
Article History
Received: 14 October 2024
Accepted: 6 December 2024
First Online: 24 December 2024
Declarations
:
: Dagny Zhu has received consulting fees and honorariums for participation in advisory boards from Alcon and Johnson & Johnson, as well as a speaker honorarium from Alcon. Alcon is a manufacturer of multiple IOLs. Mukesh Dhariwal is an employee of Alcon. ESiOR Oy received consulting fees from Alcon to conduct the study. ESiOR Oy is an expert company that carries out health economics and outcomes research HEOR, data science and evidence generation, real-world data and biobank studies, health technology assessment HTA, market access, and other services as well as provides certified secure processing environment SPESiOR® for several institutions and projects, including also the producers and marketers of IOLs. Erkki Soini is a partner of ESiOR Oy, and chairman of the board at Kuopio Health cooperative. Suyen Karki, Christian Asseburg, and Erkki Soini are employed by ESiOR Oy. Dagny Zhu, Mukesh Dhariwal, Erkki Soini, Suyen Karki and Christian Asseburg have no other conflicts of interest related to this work.
: This article is based on previously conducted studies and does not contain new studies with human participants or animals performed by any of the authors.
